GE HealthCare Technologies Inc. (GEHC)
NASDAQ · Healthcare · Medical Devices
GE HealthCare Technologies Inc. is a Healthcare company with a market capitalization of $29.91B, a trailing P/E ratio of 15.8, and a dividend yield of 0.22%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $0.99 | $1.05 | -5.7% |
| Q4 2025 | February 4, 2026 | $1.44 | $1.40 | +2.9% |
| Q3 2025 | October 29, 2025 | $0.98 | $1.00 | -2.0% |
| Q2 2025 | July 30, 2025 | $1.06 | $0.92 | +15.2% |
| Q1 2025 | April 30, 2025 | $1.01 | $0.91 | +11.0% |
| Q4 2024 | February 13, 2025 | $1.57 | $1.26 | +24.6% |
Other Medical Devices Stocks
Frequently Asked Questions
What is GE HealthCare Technologies Inc.'s market cap?
As of June 29, 2026, GE HealthCare Technologies Inc. (GEHC) has a market capitalization of $29.91B.
What is GE HealthCare Technologies Inc.'s P/E ratio?
GE HealthCare Technologies Inc. trades at a trailing price-to-earnings (P/E) ratio of 15.8. Its forward P/E is 13.4.
Does GE HealthCare Technologies Inc. pay a dividend?
Yes — GE HealthCare Technologies Inc. pays a dividend yielding 0.22%, an annual payout of $0.14 per share.
What sector is GEHC in?
GE HealthCare Technologies Inc. is in the Healthcare sector, specifically the Medical Devices industry.
What was GE HealthCare Technologies Inc.'s revenue?
In its latest reported fiscal year (ending December 31, 2025), GE HealthCare Technologies Inc. reported revenue of $20.63B and net income of $2.08B.
Ask your own questions about GEHC
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.